IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP III, LLC

Q2 2020 Holdings

Filed 2020-08-07 | 5 holdings | $685.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines, Inc.(RVMD)COM76155X100$284.9K9,024,03141.6%
Pliant Therapeutics, Inc.(PLRX)COM729139105$189.5K5,839,16027.7%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$109.0K5,962,20215.9%
Voyager Therapeutics, Inc.(VYGR)COM92915B106$80.7K6,391,17611.8%
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$21.0K3,048,7803.1%